International variation in antipsychotic prescribing for schizophrenia: Pooled results from the research on East Asia psychotropic prescription (reap) studies

Home > Journals > Biomedical & Life Sciences >OJPsych

ISSN Print: 2161-7325
ISSN Online: 2161-7333

Website: https://www.scirp.org/journal/ojpsych
E-mail: ojpsych@scirp.org

Citations h5-index & Ranking*

Submission

"International variation in antipsychotic prescribing for schizophrenia: Pooled results from the research on East Asia psychotropic prescription (reap) studies"
written by Hiroto Ito, Yasuyuki Okumura, Teruhiko Higuchi, Chay Hoon Tan, Naotaka Shinfuku,
published by Open Journal of Psychiatry, Vol.2 No.4A, 2012

has been cited by the following article(s):

[1]	Neuropsychopharmacotherapy: Differential Doses Regimes in China
	2020

[2]	Changing trends in anti-psychotic prescription pattern in Pakistan
	2019

[3]	Antipsychotic polypharmacy in the treatment of schizophrenia in China and Japan
	Australian & New Zealand Journal of Psychiatry, 2018

[4]	Enacting patient safety on the frontline an ethnographic study of rescue work with acutely illpatients
	2017

[5]	Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe …
	International Journal of Neuropsychopharmacology, 2015

[6]	Research on Asian prescription patterns (REAP): focusing on data from Japan
	2014

[7]	Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method
	International Journal of Neuropsychopharmacology, 2014

[8]	Antipsychotic Medication and Risk of QTc Prolongation: Focus on Multiple Medication and Role of Cytochrome P450 Isoforms
	Open Journal of Psychiatry, 2014

[9]	Olanzapine in Chinese patients with schizophrenia or bipolar disorder: a systematic literature review
	Neuropsychiatric disease and treatment, 2014

[10]	downloaded from the King's Research Portal at https://kclpure. kcl. ac. uk/portal

[1]	NeuroPsychopharmacotherapy 2020 DOI:10.1007/978-3-319-56015-1_22-1

[2]	Antipsychotic polypharmacy in the treatment of schizophrenia in China and Japan Australian & New Zealand Journal of Psychiatry, 2018 DOI:10.1177/0004867418805559

[3]	Evaluation of the Individual Safe Correction of Antipsychotic Agent Polypharmacy in Japanese Patients with Chronic Schizophrenia: Validation of Safe Corrections for Antipsychotic Polypharmacy and the High-Dose Method International Journal of Neuropsychopharmacology, 2015 DOI:10.1093/ijnp/pyu016

[4]	Antipsychotic Medication and Risk of QTc Prolongation: Focus on Multiple Medication and Role of Cytochrome P450 Isoforms Open Journal of Psychiatry, 2014 DOI:10.4236/ojpsych.2014.44044